Skip to main content

Table 2 Estimated parameter values for patients 1–7

From: Personalized life expectancy and treatment benefit index of antiretroviral therapy

Par. P1 P2 P3 P4 P5 P6 P7
β λ 117.95 107.65 152.83 136.51 109.63 109.92 116.75
β k 1542.68 1614.66 1873.36 1270.91 1476.14 1471.95 1606.20
α λ 0.32 0.13 0.44 0.31 0.08 0.08 0.04
α k 0.56 0.99 0.84 1.08 1.11 1.11 1.07
T m 4014 3946.7 4571.1 3739.2 3995 4002.1 4019.7
η 0.78 0.71 0.60 0.78 0.89 0.78 0.96
τ 50 117.89 39.34 383.85 30.23 52.64 55.92 31.76
τ m 15915 18055 4496 7574 17382 17277 20596
q 0.84 0.77 0.89 0.75 0.78 0.64 0.65
p 3.72 8.13 1.23 13.96 1.89 2.19 3.14
\(\bar {\beta }_{k}\) 73.35 1614.7 1869.7 12.70 1294.6 931.08 217.12
\(\bar {\alpha }_{k}\) 0.56 0.99 0.84 0.80 1.10 1.11 1.07
l 0.80 0.99 0.99 0.86 0.80 0.99 0.90
T s 2983.6 3681 3290.4 3358.7 3719.5 3521 3839.7
T r 3796.47 5070.56 3812.76 3929.77 5544.5 4424.67 4232.49
T e 4279.6 5116 4592.1 4038.7 4909 4615.4 6706.3
T d 18899.09 21736.01 7786.16 10932.50 21101.71 20798.12 24436.16
B CD4 200 100 200 50
  1. where Par. represents parameter, and Pi denote Patient i